Literature DB >> 23884411

Negative elongation factor (NELF) coordinates RNA polymerase II pausing, premature termination, and chromatin remodeling to regulate HIV transcription.

Malini Natarajan1, Gillian M Schiralli Lester, Chanhyo Lee, Anamika Missra, Gregory A Wasserman, Martin Steffen, David S Gilmour, Andrew J Henderson.   

Abstract

A barrier to eradicating HIV infection is targeting and eliminating latently infected cells. Events that contribute to HIV transcriptional latency include repressive chromatin structure, transcriptional interference, the inability of Tat to recruit positive transcription factor b, and poor processivity of RNA polymerase II (RNAP II). In this study, we investigated mechanisms by which negative elongation factor (NELF) establishes and maintains HIV latency. Negative elongation factor (NELF) induces RNAP II promoter proximal pausing and limits provirus expression in HIV-infected primary CD4(+) T cells. Decreasing NELF expression overcomes RNAP II pausing to enhance HIV transcription elongation in infected primary T cells, demonstrating the importance of pausing in repressing HIV transcription. We also show that RNAP II pausing is coupled to premature transcription termination and chromatin remodeling. NELF interacts with Pcf11, a transcription termination factor, and diminishing Pcf11 in primary CD4(+) T cells induces HIV transcription elongation. In addition, we identify NCoR1-GPS2-HDAC3 as a NELF-interacting corepressor complex that is associated with repressed HIV long terminal repeats. We propose a model in which NELF recruits Pcf11 and NCoR1-GPS2-HDAC3 to paused RNAP II, reinforcing repression of HIV transcription and establishing a critical checkpoint for HIV transcription and latency.

Entities:  

Keywords:  HIV; RNA Polymerase II; Transcription Elongation Factors; Transcription Regulation; Transcription Repressor

Mesh:

Substances:

Year:  2013        PMID: 23884411      PMCID: PMC3764804          DOI: 10.1074/jbc.M113.496489

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  70 in total

Review 1.  A compilation of cellular transcription factor interactions with the HIV-1 LTR promoter.

Authors:  L A Pereira; K Bentley; A Peeters; M J Churchill; N J Deacon
Journal:  Nucleic Acids Res       Date:  2000-02-01       Impact factor: 16.971

2.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.

Authors:  K J Livak; T D Schmittgen
Journal:  Methods       Date:  2001-12       Impact factor: 3.608

Review 3.  The control of HIV transcription: keeping RNA polymerase II on track.

Authors:  Melanie Ott; Matthias Geyer; Qiang Zhou
Journal:  Cell Host Microbe       Date:  2011-11-17       Impact factor: 21.023

4.  Histone acetyltransferases regulate HIV-1 enhancer activity in vitro.

Authors:  P L Sheridan; T P Mayall; E Verdin; K A Jones
Journal:  Genes Dev       Date:  1997-12-15       Impact factor: 11.361

5.  The human factors YY1 and LSF repress the human immunodeficiency virus type 1 long terminal repeat via recruitment of histone deacetylase 1.

Authors:  J J Coull; F Romerio; J M Sun; J L Volker; K M Galvin; J R Davie; Y Shi; U Hansen; D M Margolis
Journal:  J Virol       Date:  2000-08       Impact factor: 5.103

6.  Histone deacetylase 3 represses HTLV-1 tax transcription.

Authors:  Raul Villanueva; Antonio H Iglesias; Sandra Camelo; Luis C Sanin; Steven G Gray; Fernando Dangond
Journal:  Oncol Rep       Date:  2006-09       Impact factor: 3.906

7.  Histone deacetylases and the nuclear receptor corepressor regulate lytic-latent switch gene 50 in murine gammaherpesvirus 68-infected macrophages.

Authors:  Megan M Goodwin; Jerome M Molleston; Susan Canny; Mohamed Abou El Hassan; Erin K Willert; Rod Bremner; Herbert W Virgin
Journal:  J Virol       Date:  2010-08-18       Impact factor: 5.103

8.  Antiretroviral intensification and valproic acid lack sustained effect on residual HIV-1 viremia or resting CD4+ cell infection.

Authors:  Nancie M Archin; Manzoor Cheema; Daniel Parker; Ann Wiegand; Ronald J Bosch; John M Coffin; Joseph Eron; Myron Cohen; David M Margolis
Journal:  PLoS One       Date:  2010-02-23       Impact factor: 3.240

9.  Attenuation of estrogen receptor alpha-mediated transcription through estrogen-stimulated recruitment of a negative elongation factor.

Authors:  Sarah E Aiyar; Jian-long Sun; Ashley L Blair; Christopher A Moskaluk; Yun-zhe Lu; Qi-Nong Ye; Yuki Yamaguchi; Amitava Mukherjee; Da-ming Ren; Hiroshi Handa; Rong Li
Journal:  Genes Dev       Date:  2004-09-01       Impact factor: 11.361

10.  Chromatin disruption in the promoter of human immunodeficiency virus type 1 during transcriptional activation.

Authors:  E Verdin; P Paras; C Van Lint
Journal:  EMBO J       Date:  1993-08       Impact factor: 11.598

View more
  37 in total

1.  RNAP II processivity is a limiting step for HIV-1 transcription independent of orientation to and activity of endogenous neighboring promoters.

Authors:  Katarzyna Kaczmarek Michaels; Frank Wolschendorf; Gillian M Schiralli Lester; Malini Natarajan; Olaf Kutsch; Andrew J Henderson
Journal:  Virology       Date:  2015-09-14       Impact factor: 3.616

2.  PIWIL4 Maintains HIV-1 Latency by Enforcing Epigenetically Suppressive Modifications on the 5' Long Terminal Repeat.

Authors:  Zhangping He; Shuliang Jing; Tao Yang; Jingliang Chen; Feng Huang; Wanying Zhang; Zhilin Peng; Bingfeng Liu; Xiancai Ma; Liyang Wu; Ting Pan; Xu Zhang; Linghua Li; Weiping Cai; Xiaoping Tang; Junsong Zhang; Hui Zhang
Journal:  J Virol       Date:  2020-05-04       Impact factor: 5.103

3.  Mining the human complexome database identifies RBM14 as an XPO1-associated protein involved in HIV-1 Rev function.

Authors:  Sona Budhiraja; Hongbing Liu; Jacob Couturier; Anna Malovannaya; Jun Qin; Dorothy E Lewis; Andrew P Rice
Journal:  J Virol       Date:  2015-01-14       Impact factor: 5.103

4.  Negative elongation factor is required for the maintenance of proviral latency but does not induce promoter-proximal pausing of RNA polymerase II on the HIV long terminal repeat.

Authors:  Julie K Jadlowsky; Julian Y Wong; Amy C Graham; Curtis Dobrowolski; Renee L Devor; Mark D Adams; Koh Fujinaga; Jonathan Karn
Journal:  Mol Cell Biol       Date:  2014-03-17       Impact factor: 4.272

Review 5.  Transcriptional control of HIV latency: cellular signaling pathways, epigenetics, happenstance and the hope for a cure.

Authors:  Uri Mbonye; Jonathan Karn
Journal:  Virology       Date:  2014-02-22       Impact factor: 3.616

6.  Super elongation complex promotes early HIV transcription and its function is modulated by P-TEFb.

Authors:  Alona Kuzmina; Simona Krasnopolsky; Ran Taube
Journal:  Transcription       Date:  2017-02-17

7.  Mitochondrial Retrograde Signaling in Mammals Is Mediated by the Transcriptional Cofactor GPS2 via Direct Mitochondria-to-Nucleus Translocation.

Authors:  Maria Dafne Cardamone; Bogdan Tanasa; Carly T Cederquist; Jiawen Huang; Kiana Mahdaviani; Wenbo Li; Michael G Rosenfeld; Marc Liesa; Valentina Perissi
Journal:  Mol Cell       Date:  2018-03-01       Impact factor: 17.970

Review 8.  Multiple Inhibitory Factors Act in the Late Phase of HIV-1 Replication: a Systematic Review of the Literature.

Authors:  Jean-François Gélinas; Deborah R Gill; Stephen C Hyde
Journal:  Microbiol Mol Biol Rev       Date:  2018-01-10       Impact factor: 11.056

Review 9.  Progress and challenges in the use of latent HIV-1 reactivating agents.

Authors:  Hong-tao Shang; Ji-wei Ding; Shu-ying Yu; Tao Wu; Qiu-li Zhang; Fu-jun Liang
Journal:  Acta Pharmacol Sin       Date:  2015-06-01       Impact factor: 6.150

10.  Assays for precise quantification of total (including short) and elongated HIV-1 transcripts.

Authors:  Philipp Kaiser; Sunil K Joshi; Peggy Kim; Peilin Li; Hongbing Liu; Andrew P Rice; Joseph K Wong; Steven A Yukl
Journal:  J Virol Methods       Date:  2016-12-27       Impact factor: 2.014

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.